Wella IPO: Inside KKR's $2.9B-Revenue Beauty Company's S-1

The Wella IPO has not priced. As of September 27, 2026, KKR's hair and nail company has an amended S-1 on file with the SEC, dated September 23, that still leaves the price range, share count and deal size blank, while disclosing $2.29 billion of term-loan debt the offering is built to help refinance.

The filing does show a 145-year-old professional beauty business that has swung from losses to a thin profit under private-equity ownership. This deep dive reads the September 23 amendment and the original August 31 S-1: how Wella makes money, who owns what after Coty's exit, what the risk factors flag, and where the deal sits in a wobbling fall IPO calendar.

Wella IPO: Company Snapshot

The Wella Company is, according to its S-1 filing, the world's largest pure-play hair and nail company: Wella Professionals, OPI, ghd, Clairol, Nioxin and Sebastian Professional, sold in more than 100 countries. KKR carved it out of Coty in 2020 and still controls it. The shares would trade on the NYSE as WELA.

Sources: Wella S-1/A (September 23, 2026); founding detail from Reuters.

What Wella Actually Does

Wella sells hair color, care, styling and treatment products, nail lacquers and care, and heat- and air-assisted styling tools. It serves more than 250,000 hair and nail salons, and a direct sales organization of over 750 representatives sells straight into more than 65,000 of them, backed by more than 300 educators who train stylists, according to the S-1/A.

The go-to-market logic is the filing's key idea. Wella calls it “Gain with Color, Grow with Care”: win a salon with hair color, which the S-1 calls the main revenue driver of most salons and a system with high switching costs, then sell it care and styling lines. In fiscal 2026, 76% of Wella's color accounts also bought care products, and salons served by its direct sales force had a 97% revenue retention rate.

Behind that sit more than 300 scientists across six R&D centers, more than 1,200 granted and pending patents, and three factories in North America, Europe and Asia that make roughly 60% of its hair and nail products.

How Wella Makes Money

Wella reports two segments. Hair & Nail, which covers professional hair, retail hair and nail, produced $2.48 billion of fiscal 2026 net revenue; Beauty Tech, which is ghd alone, produced $458.9 million (the filing's product-category table puts ghd's Styling Tools revenue slightly higher, at $478.5 million). By product category, professional hair is more than half the business, and nail, despite the “OPI nail polish owner” headlines, is under 8% of it.

The mix is moving toward consumers: consumer channels rose from about 45% of net invoiced sales in fiscal 2023 to about 52% in fiscal 2026. The United States generated about 25% of fiscal 2026 net revenue ($723.8 million), ahead of Germany ($336.4 million) and the United Kingdom ($327.8 million).

Pricing does real work: the filing attributes roughly half of fiscal 2026's constant-currency growth to net pricing. And three customers accounted for 19% of fiscal 2026 net revenue, though none individually crossed 10%.

Funding and Ownership History

Wella's capital history is not a venture story. It is a private-equity carve-out followed by a five-year handoff from Coty to KKR. The two signed a memorandum of understanding in May 2020 at a contemplated enterprise value of $4.3 billion, or 12.3x 2019 EBITDA, with KKR taking 60%, according to Coty's announcement. The deal closed on November 30, 2020; Coty took about $2.5 billion in net cash and kept 40%, a stake it initially valued at $1.3 billion, per its completion release.

Sources: Coty 8-K exhibits (May and December 2020), Coty (December 19, 2025), Wella S-1/A consolidated financial statements note 1, and Wella's EDGAR filing index.

The December 2025 exit is the detail most coverage skips. Coty sold to Tides Holdco Limited, which the filing says is owned 77.5% by a KKR vehicle and 22.5% by Coty, and the S-1 now describes Coty as holding only an indirect, non-voting interest. One read on this: Coty still has an economic reason to want a strong IPO price, but no vote on it.

Product Portfolio

The S-1 names seven strategic brands. Wella also owns brands including Briogeo, System Professional, Kadus and Londa.

Source: The Wella Company Form S-1/A, September 23, 2026. Rankings are the company's own claims as stated in the filing.

The Offering: What the S-1 Says and What It Leaves Blank

The September 23 cover describes a primary offering, “We are offering shares of our common stock,” with share count, price range and proceeds blank, and the amendment names no selling stockholders. Goldman Sachs, BofA Securities, KKR and J.P. Morgan top a list of 21 banks; because KKR Capital Markets is an affiliated underwriter, the deal runs under FINRA Rule 5121 with Goldman Sachs as qualified independent underwriter.

The money has a job. Wella says it will combine net proceeds with borrowings under a new senior facilities agreement to repay its existing Facility B term loans in full, and use part of the proceeds for tax withholding tied to converting management and employee equity. That existing debt comes in three currencies: a $175 million Facility B1, a €1,215 million Facility B2 and a £550 million Facility B3, all maturing February 26, 2029. The replacement package consists of €850 million, $500 million and £100 million term loans plus a $500 million revolver. And an affiliate of KKR is among the Facility B lenders being repaid.

The capital structure explains why the price matters so much to insiders. The pre-IPO parent, Rainbow Capital Group Limited, has preference shares whose liquidation preference grows with accrued dividends, and the filing states that at the assumed midpoint price (itself still blank), equity value falls short of the B preference shares' preference, so ordinary shareholders receive no common stock in the exchange. Add Coty's claim on proceeds above KKR's preferred return, and a “We own our way” employee program funded from about 4% of equity value growth since KKR's 2020 acquisition, and the price does more than set a market value. It decides who in the old structure gets paid.

After the offering, the KKR Stockholders will still hold more than 50% of the voting power, making Wella a “controlled company” under NYSE rules. Lock-ups run 180 days, no dividends are planned, and a monitoring agreement with KKR (and, until December 2025, Coty) that cost $4.6 million in fiscal 2026 ends at the IPO, triggering a termination fee to KKR (amount blank).

Revenue and Key Metrics

Source: The Wella Company Form S-1/A, summary historical consolidated financial data and MD&A. Adjusted EBITDA and free cash flow are non-GAAP measures defined by the company; figures from the filing's thousands are rounded to one decimal.

Reported growth flatters the latest year. Net revenue rose 9.2% in fiscal 2026, but exchange rates contributed $108.4 million of that; in constant currency the gain was 5.1%, almost identical to fiscal 2025's 5.2%. The filing also says Wella has now logged 22 consecutive quarters of year-over-year constant-currency growth.

The profit line needs a second look. Only $2.7 million of consolidated net income was attributable to Rainbow Capital Group Limited, the pre-IPO parent; $58.7 million went to redeemable non-controlling interests to cover preference dividends that accrue at 6% on A1 and 8% on B1 through B4 shares. Interest still eats most of operating income, though it fell after a €249.6 million prepayment of a payment-in-kind loan in March 2025.

Write-downs keep recurring, too. Wella booked $84.2 million of trademark impairments in fiscal 2026: $55.7 million for Briogeo US, $13.0 million for Briogeo International and $15.5 million for OPI. Briogeo has now been written down in each of the last three fiscal years, including $96.6 million on the US trademark in fiscal 2024.

Our arithmetic on leverage: debt at June 30, 2026 was more than 4.3x fiscal 2026 adjusted EBITDA, or more than 3.7x net of the $322.3 million of cash on hand. One aim of the IPO and refinancing is to bring that ratio down.

Competitive Landscape

The filing names its rivals: the hair and nail businesses of L'Oréal, Henkel, Kao, Unilever and Estée Lauder, and, for ghd, devices from SharkNinja, Dyson and L'Oréal Professionnel. The field is consolidating: the S-1 notes Olaplex announced on March 26, 2026 that Henkel would acquire it.

The most useful public comparison is L'Oréal's Professional Products Division, home of L'Oréal Professionnel, Redken and Kérastase. Its 2025 sales came to €5,163.0 million, up 7.5% like-for-like, and passed €5 billion for the first time, with a divisional operating margin of 22.9%, according to L'Oréal's 2025 annual results.

Not like-for-like: Wella's growth is constant currency and its margin is adjusted EBITDA; L'Oréal's growth is like-for-like and its margin is divisional operating profit, which is struck after depreciation, so the true gap is likely wider than the bars show.

One read: Wella is smaller, slower-growing and less profitable than L'Oréal's larger professional division, so its pitch leans on focus: salon color systems that are hard to rip out, plus ghd.

Leadership Team

The bench is heavy with L'Oréal alumni: revenue chief Hugo Kunetz, marketing chief Yannis Rodocanachi and ghd CEO Jeroen Temmerman each spent 18 to more than 20 years there. The board includes KKR Partner Nancy Ford, KKR director Rupert Pedler and KKR senior advisor Sir Roger Carr.

Bull Case / Bear Case

IPO Outlook

As of September 27, 2026, the Wella IPO has not priced and there is no price range to anchor a valuation. Wella's EDGAR filing index shows a confidential draft registration on April 17, 2026, three draft amendments, the public S-1 and Amendment No. 1, and no final 424B prospectus. Renaissance Capital's WELA profile lists the price range as n/a; the firm estimated at filing it could raise more than $500 million, an outside estimate, not a company figure.

On valuation, the only marker is reporting: Reuters, recapping its own earlier reporting in an August 31 story on the filing, said the offering could meaningfully exceed the carve-out value KKR paid in 2020. Treat that as reporting, not terms. For context, Coty said in June 2020 that the $4.3 billion price equated to 12.3x fiscal 2019 adjusted EBITDA of about $350 million on a fully allocated basis, including about $160 million of central costs that would not transfer, so that multiple is not directly comparable with Wella's current adjusted EBITDA. No valuation will exist until Wella files a price range.

Timing depends on a market that softened in September. Renaissance Capital's third-quarter review counted 31 US listings raising $34.9 billion, but SK hynix's $26.5 billion offering was most of that; excluding it, proceeds were $8.4 billion, as AI-spending worries, a 19-year high in bond yields and resumed rate hikes weighed on the fall. In the week of September 21, Bamboo Insurance Services postponed a $665 million IPO at the eleventh hour, while ADARx Pharmaceuticals priced at the top of its range to raise $446 million, per the firm's weekly recap.

Other large deals are testing the same window. Consumer device maker Oura has set terms to raise $2.1 billion at a $15.0 billion market cap, with existing shareholders selling 73% of the deal, and PE-backed data-center supplier Accelevation plans a $660 million IPO, according to Renaissance Capital's week-ahead calendar. Reuters reported on August 31 that Permira-backed Reformation had gone public the prior month, raising $211 million. See our Oura IPO breakdown, the sponsor-owned Panera Brands IPO, and for the full calendar, our 2026 IPO pipeline tracker and biggest IPOs of 2026.

What to watch next: an amendment that fills in the price range and share count; whether any existing holders are added as sellers; and the post-IPO voting percentage KKR discloses, which will show how much control public investors are buying into.

The Bottom Line

Wella is a real, cash-generating business with a salon color moat competitors must dislodge one salon at a time, plus a fast-improving device brand in ghd. It is also a leveraged sponsor carve-out whose reported profit shrinks once preferred claims are allocated, whose fiscal 2022 Briogeo acquisition has been written down three years running, and whose growth trails L'Oréal's professional division. The IPO is best read as a refinancing and a path to liquidity for KKR and, indirectly, Coty. What public investors will pay is the key number the filing still omits. We will update this post when terms land.

Figures come from Wella's S-1 and S-1/A (through September 23, 2026), Coty and L'Oréal disclosures, Reuters and Renaissance Capital. The IPO had not priced as of September 27, 2026; terms may change. Leverage figures are our arithmetic. Not investment advice.